mRNA vaccine: a potential therapeutic strategy
Top Cited Papers
Open Access
- 16 February 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 20 (1), 1-23
- https://doi.org/10.1186/s12943-021-01311-z
Abstract
MRNA vaccines have tremendous potential to fight against cancer and viral diseases due to superiorities in safety, efficacy and industrial production. In recent decades, we have witnessed the development of different kinds of mRNAs by sequence optimization to overcome the disadvantage of excessive mRNA immunogenicity, instability and inefficiency. Based on the immunological study, mRNA vaccines are coupled with immunologic adjuvant and various delivery strategies. Except for sequence optimization, the assistance of mRNA-delivering strategies is another method to stabilize mRNAs and improve their efficacy. The understanding of increasing the antigen reactiveness gains insight into mRNA-induced innate immunity and adaptive immunity without antibody-dependent enhancement activity. Therefore, to address the problem, scientists further exploited carrier-based mRNA vaccines (lipid-based delivery, polymer-based delivery, peptide-based delivery, virus-like replicon particle and cationic nanoemulsion), naked mRNA vaccines and dendritic cells-based mRNA vaccines. The article will discuss the molecular biology of mRNA vaccines and underlying anti-virus and anti-tumor mechanisms, with an introduction of their immunological phenomena, delivery strategies, their importance on Corona Virus Disease 2019 (COVID-19) and related clinical trials against cancer and viral diseases. Finally, we will discuss the challenge of mRNA vaccines against bacterial and parasitic diseases.Keywords
Funding Information
- the National Natural Science Foundation Regional Innovation and Development (U19A2003)
- National Major Scientific and Technological Special Project for “Significant New Drugs Development” (No. 2018ZX09733001)
- the Excellent Youth Foundation of Sichuan Scientific Committee Grant in China (No. 2019JDJQ008)
- the Development Program of China (No.2016YFA0201402)
This publication has 223 references indexed in Scilit:
- A novel post-transcriptional role for ubiquitin in the differential regulation of MHC class I allotypesMolecular Immunology, 2013
- IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunityJCI Insight, 2013
- Sounds of silence: synonymous nucleotides as a key to biological regulation and complexityNucleic Acids Research, 2013
- Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2012
- Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapyJournal of Controlled Release, 2011
- Conformational change of single-stranded RNAs induced by liposome bindingNucleic Acids Research, 2011
- Role of 5′‐ and 3′‐untranslated regions of mRNAs in human diseasesBiology of the Cell, 2009
- Type 2 Bias of T Cells Expanded from the Blood of Melanoma Patients Switched to Type 1 byIL-12p70mRNA–Transfected Dendritic CellsCancer Research, 2008
- Improved native affinity purification of RNARNA, 2007
- High Guanine and Cytosine Content Increases mRNA Levels in Mammalian CellsPLoS Biology, 2006